Lee M, Shorthouse D, Mahen R, Hall B, Venkitaraman A. Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Nucleic Acids Res. 2021;49:5588-5604 pubmed publisher

Tseng W, Chen C, Chern C, Wang C, Lee W, Chi Y, et al. Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells. Int J Mol Sci. 2021;22: pubmed publisher

Clements K, Thakar T, Nicolae C, Liang X, Wang H, Moldovan G. Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells. Nucleic Acids Res. 2018;46:8898-8907 pubmed publisher